drugset / Trial / NCT03927326

Postoperative Analgesia in Laparoscopic Abdominal Surgery After Exparel Via TAP or Local Infiltration

NCT03927326 ↗

Unknown 150 enrolled University of Washington
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates differences in how administering liposomal bupivacaine via two different methods affects postoperative pain control in laparoscopic abdominal surgery patients. Half the participants will receive liposomal bupivacaine via a transverses abdominis plane block while the other half will receive liposomal bupivacaine via local infiltration.

Timeline

Start
2019-08
Primary completion
2020-07
Completion
2020-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 266 mg Other

Indications

No indication recorded.